X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
female (23) 23
middle aged (23) 23
aged (21) 21
male (21) 21
adult (19) 19
hematology (14) 14
index medicus (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
chemotherapy (11) 11
rituximab (11) 11
aged, 80 and over (10) 10
cancer (9) 9
oncology (9) 9
prognosis (8) 8
retrospective studies (8) 8
survival (8) 8
adolescent (7) 7
lymphoma, follicular - drug therapy (7) 7
lymphomas (7) 7
treatment outcome (7) 7
doxorubicin - administration & dosage (6) 6
cyclophosphamide - administration & dosage (5) 5
follow-up studies (5) 5
life sciences (5) 5
lymphoma (5) 5
non-hodgkins-lymphoma (5) 5
prednisone - administration & dosage (5) 5
risk factors (5) 5
therapy (5) 5
vincristine - administration & dosage (5) 5
young adult (5) 5
analytical chemistry (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
chemical sciences (4) 4
clinical trials (4) 4
disease-free survival (4) 4
lymphoma, follicular - mortality (4) 4
neoplasm staging (4) 4
prednisone (4) 4
remission induction (4) 4
safety (4) 4
selenium (4) 4
survival analysis (4) 4
vincristine (4) 4
[ chim.anal ] chemical sciences/analytical chemistry (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
[sdv.can]life sciences [q-bio]/cancer (3) 3
age factors (3) 3
anaplastic large-cell lymphoma (3) 3
antibodies, monoclonal, murine-derived (3) 3
antibodies, monoclonal, murine-derived - administration & dosage (3) 3
antineoplastic agents - therapeutic use (3) 3
bleomycin - administration & dosage (3) 3
care and treatment (3) 3
cohort studies (3) 3
cyclophosphamide (3) 3
disease (3) 3
doxorubicin (3) 3
efficacy (3) 3
fluorodeoxyglucose f18 (3) 3
follicular lymphoma (3) 3
immunohistochemistry (3) 3
lymphoma, large-cell, anaplastic - drug therapy (3) 3
lymphoma, non-hodgkin - drug therapy (3) 3
mass spectrometry (3) 3
multivariate analysis (3) 3
non-hodgkin-lymphoma (3) 3
pathology (3) 3
positron-emission tomography (3) 3
prospective studies (3) 3
selenoprotein (3) 3
time factors (3) 3
transplantation (3) 3
[ chim ] chemical sciences (2) 2
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (2) 2
[chim.anal]chemical sciences/analytical chemistry (2) 2
[chim.mate]chemical sciences/material chemistry (2) 2
[chim.poly]chemical sciences/polymers (2) 2
[chim.theo]chemical sciences/theoretical and/or physical chemistry (2) 2
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (2) 2
acute leukemia (2) 2
adults (2) 2
alk protein (2) 2
anti-cd20 monoclonal-antibody (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols (2) 2
b-cell lymphoma (2) 2
biomarkers, tumor - analysis (2) 2
biopsy (2) 2
bone-marrow transplantation (2) 2
child (2) 2
clinical trials as topic (2) 2
comparative analysis (2) 2
compassionate use (2) 2
confidence intervals (2) 2
cyclophosphamide - therapeutic use (2) 2
doxorubicin - therapeutic use (2) 2
elderly-patients (2) 2
employment (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
2009, Jobs for youth = Des emplois pour les jeunes. France, ISBN 9264061967, Volume 2009
Web Resource
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 23, pp. 3194 - 3200
Journal Article
Journal Article
African Journal of Health Professions Education, 06/2017, Volume 9, Issue 2, pp. 62 - 66
Background. Students who fail the first semester in an undergraduate medical programme at the University of the Free State may join a Learning Development... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2019, Volume 37, Issue 31, pp. 2815 - 2824
PURPOSE The PRIMA study (ClinicalTrials.gov identifier: NCT00140582 ) established that 2 years of rituximab maintenance after first-line immunochemotherapy... 
Journal Article
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 10, pp. 2085 - 2093
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2018, Volume 183, Issue 1, pp. 76 - 86
Journal Article
Haematologica, ISSN 0390-6078, 07/2013, Volume 98, Issue 7, pp. 1107 - 1114
Journal Article
2008, Jobs for youth = Des emplois pour les jeunes. Canada, ISBN 9789264046702, Volume 2008
Web Resource
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 83, p. 146
Background: Long-term outcomes of adults with first-relapsed/refractory (R/R) systemic anaplastic large-cell lymphoma (ALCL) are not definitively established... 
Medical research | Clinical trials | Drug development | Patients | Lymphoma | Survival | Confidence intervals | Prescription drugs | Chemotherapy | Adults | Lymphomas | Anaplastic large-cell lymphoma | Protein-tyrosine kinase
Journal Article
Journal Article